LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma
Clinical trial NCT00859222 · COMPLETED
Trial details
- NCT number
- NCT00859222
- Sponsor
- Patrick Y. Wen, MD
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2013-09-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.